Disease Area Leader Cardiovascular, Renal and Metabolism (CVRM)

at  Roche

Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.
The Position
Roche - we advance science so that we all have more time with the people we love
Our Pharma Global Product Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary professional who thrives in a collaborative environment and is passionate about making a difference.
The Disease Area Leader - Cardiovascular, Renal and Metabolism (CVRM) role is critical to deliver on our Pharma Ambition. As the therapeutic area Late-Stage conduit into our early development teams, the Disease Area Leader plays a unique role in providing strategic insights and commercialization perspective to shape and steward our portfolio and create clarity on path to value, in particular through contribution to Asset and Disease Area Strategies and Business Development assessments.

Key Responsibilities

• Asset Team member for Research and Early Development (REDs): Partner with R&Ds units and cross-functionally to ensure organizational alignment around understanding of future disease area context and ensure pipeline Asset strategies and Disease Strategies reflect value to patients, society and Roche. This includes providing global strategic guidance and business inputs into the development of Target Product Profiles, Clinical Development Plans with strong emphasis on value demonstration for pipeline molecules (until PivGo or LCL assigned)
• Disease Area Strategy: lead a cross-functional end-to-end team in the development and maintenance of disease area strategies that reflects near and long term pipeline portfolio evolution to deliver value to patients, society and Roche.
• Partnering GPS TA SPOC: Represent GPS in assessment of external landscape and partnering opportunities in the context of Disease Area Strategies and provide specific asset and platform/technology business input, path to value assessments and strategic guidance to support due diligence.
• Cross-Functional Team Leadership: In partnership with CLT, lead the integrated development and commercialization planning (IDCP) process to bring affiliate inputs into asset and disease area strategies and decision making.

Who You Are

• Scientific and commercial understanding of Therapeutic area (in particular in the Prioritized Disease area). with an established network of external stakeholders is preferred. Development, Portfolio, Partnering, Commercialization, Consulting and/or Medical Affairs team experience preferred. MBA, MD, PhD or other relevant Graduate or Postgraduate Degree is preferred.
• Outstanding VACC (Visionary, Architect, Catalyst and Coach) leadership skills: proven track record in building teams and ability to influence in a collaborative way within a cross functional environment
• Exceptional strategic orientation and agility: outstanding ability to develop long term vision and deep understanding of the global pharmaceutical/biotechnology industry to create robust and innovative business strategies
• Proven abilities to lead, collaborate and deliver in a complex and matrix environment, across across multiple priorities and stakeholders
• Extensive experience in development and implementation of commercialization strategies, deep understanding of global health systems and access/reimbursement challenges, and product life-cycle planning and management
• Fluent written and verbal English

Join us in our mission to advance science and deliver hope to those who need it most.
Who we are
At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.
Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.
Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.
We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

• Asset Team member for Research and Early Development (REDs): Partner with R&Ds units and cross-functionally to ensure organizational alignment around understanding of future disease area context and ensure pipeline Asset strategies and Disease Strategies reflect value to patients, society and Roche. This includes providing global strategic guidance and business inputs into the development of Target Product Profiles, Clinical Development Plans with strong emphasis on value demonstration for pipeline molecules (until PivGo or LCL assigned)
• Disease Area Strategy: lead a cross-functional end-to-end team in the development and maintenance of disease area strategies that reflects near and long term pipeline portfolio evolution to deliver value to patients, society and Roche.
• Partnering GPS TA SPOC: Represent GPS in assessment of external landscape and partnering opportunities in the context of Disease Area Strategies and provide specific asset and platform/technology business input, path to value assessments and strategic guidance to support due diligence.
• Cross-Functional Team Leadership: In partnership with CLT, lead the integrated development and commercialization planning (IDCP) process to bring affiliate inputs into asset and disease area strategies and decision making